The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding available to healthcare companies, says a ne
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.